![Myriam Mendila](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Myriam Mendila
Teknisk/Vetenskaplig/F&U Direktör på
CUREVAC
Profil
Myriam Mendila currently works at CureVac NV, as Chief Scientific Officer, Head-R&D.
Dr. Mendila also formerly worked at Novartis Pharma AG, as Chief Medical Officer-Oncology.
Dr. Mendila received her doctorate degree from Hannover Medical School.
Aktiva positioner av Myriam Mendila
| Företag | Position | Start |
|---|---|---|
| CUREVAC | Teknisk/Vetenskaplig/F&U Direktör | - |
Tidigare kända positioner av Myriam Mendila
| Företag | Position | Slut |
|---|---|---|
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Företagsledare/Principal | - |
Myriam Mendilas utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
1
Första gradens relationer
3
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
Hannover Medical School
 Hannover Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
CureVac NV
 CureVac NV BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops medicines based on messenger ribonucleic acid which includes prophylactic vaccines, oncology, and molecular therapies | Health Technology |
